Loading…
Lobbying Spend
—
Filings
100
Firms Hired
3
Active Period
2011–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to regulation of pharmaceuticals. H.R.1476-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act).
Client expense: — · Firm income: $60,000
Matched citations: H.R.1476
Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to regulation of pharmaceuticals. H.R.1476-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act).
Client expense: — · Firm income: $60,000
Matched citations: H.R.1476
Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to regulation of pharmaceuticals. H.R.1476-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act).
Client expense: — · Firm income: $50,000
Matched citations: H.R.1476
Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to regulation of pharmaceuticals. H.R.1476-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act).
Client expense: — · Firm income: $50,000
Matched citations: H.R.1476
Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to regulation of pharmaceuticals. H.R.1476-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act).
Client expense: — · Firm income: $40,000
Matched citations: H.R.1476
Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. 6465/S. 4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6465
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. 6465/S. 4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6465
Legislative and regulatory issues related to gene therapies for hemophilia B; Issues related to plasma and plasma derived therapies; Issues related to H.R. 6465/S. 4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6465
Legislative and regulatory issues related to gene therapies for hemophilia B; Issues related to plasma and plasma derived therapies; Issues related to H.R. 6465/S. 4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 4741
Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. 6465/S. 4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 4741
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. 6465/S. 4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 4741
Issues related to legislative and regulatory issues related to gene therapies for hemophilia B. Issues related to plasma and plasma derived therapies. Issues related to H.R. 6465/S.4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6465
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Rx pricing. Issues related to plasma and plasma derived therapies. Issues related to H.R. 6465/S.4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6465
Issues related to Rx pricing. Issues related to plasma and plasma derived therapies. Issues related to H.R. 6465/S.4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6465
Issues related to legislative and regulatory issues related to gene therapies for hemophilia B. Issues related to plasma and plasma derived therapies. Issues related to H.R. 6465/S.4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: S.4741
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Rx pricing. Issues related to plasma and plasma derived therapies. Issues related to H.R. 6465/S.4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: S.4741
Issues related to Rx pricing. Issues related to plasma and plasma derived therapies. Issues related to H.R. 6465/S.4741 - Preserving Life-saving Access to Specialty Medicines in America Act.
Client expense: — · Firm income: $60,000
Matched citations: S.4741
Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Rx pricing.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5376
Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Rx pricing.
Client expense: — · Firm income: $120,000
Matched citations: H.R. 5376
Issues related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Rx pricing.
Client expense: — · Firm income: $120,000
Matched citations: H.R. 5376
Issues related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Rx pricing.
Client expense: — · Firm income: —
Matched citations: H.R. 5376
Issues related to H.R.5376 - Build Back Better Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5376
Issues related to H.R.5376 - Build Back Better Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5376
Issues related to H.R.5376 - Build Back Better Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5376
Issues related to H.R. 925 - The Heroes Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 925
Source: Senate LDA